Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Environ Sci Technol ; 57(49): 20951-20961, 2023 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-38009568

RESUMO

Biogenic sulfidation of zero-valent iron (ZVI) using sulfate reducing bacteria (SRB) has shown enhanced dechlorination rates comparable to those produced by chemical sulfidation. However, controlling and sustaining biogenic sulfidation to enhance in situ dechlorination are poorly understood. Detailed interactions between SRB and ZVI were examined for 4 months in column experiments under enhanced biogenic sulfidation conditions. SRB proliferation and changes in ZVI surface properties were characterized along the flow paths. The results show that ZVI can stimulate SRB activity by removing excessive free sulfide (S2-), in addition to lowering reduction potential. ZVI also hinders downgradient movement of SRB via electrostatic repulsion, restricting SRB presence near the upgradient interface. Dissolved organic carbon (e.g., >2.2 mM) was essential for intense biogenic sulfidation in ZVI columns. The presence of SRB in the upgradient zone appeared to promote the formation of iron polysulfides. Biogenic FeSx deposition increased the S content on ZVI surfaces ∼3-fold, corresponding to 3-fold and 2-fold improvements in the trichloroethylene degradation rate and electron efficiency in batch tests. Elucidation of SRB and ZVI interactions enhances sustained sulfidation in ZVI permeable reactive barrier.


Assuntos
Ferro , Poluentes Químicos da Água , Ferro/química , Poluentes Químicos da Água/química , Elétrons
2.
Chemosphere ; 313: 137512, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36495971

RESUMO

Knowledge of the fate and transport of nanoscale zero-valent iron (nZVI) in saturated porous media is crucial to the development of in situ remediation technologies. This work systematically compared the retention and transport of carboxymethyl cellulose (CMC) modified nZVI (CMC-nZVI) and sulfidated nZVI (CMC-S-nZVI) particles in saturated columns packed with quartz sand of various grain sizes and different surface metal oxide coatings. Grain size reduction had an inhibitory effect on the transport of CMC-S-nZVI and CMC-nZVI due to increasing immobile zone deposition and straining in the columns. Metal oxide coatings had minor effect on the transport of CMC-S-nZVI and CMC-nZVI because the sand surface was coated by the free CMC in the suspensions, reducing the electrostatic attraction between the nZVI and surface metal oxides. CMC-S-nZVI displayed greater breakthrough (C/C0 = 0.82-0.90) and higher mass recovery (84.9%-89.3%) than CMC-nZVI (C/C0 = 0.70-0.80 and mass recovery = 70.9%-79.6%, respectively) under the same experimental conditions. A mathematical model based on the advection-dispersion equation simulated the experimental data of nZVI breakthrough curves very well. Findings of this study suggest sulfidation could enhance the transport of CMC-nZVI in saturated porous media with grain and surface heterogeneities, promoting its application in situ remediation.


Assuntos
Ferro , Nanopartículas Metálicas , Porosidade , Areia , Quartzo , Carboximetilcelulose Sódica
3.
Int J Biol Macromol ; 62: 287-90, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24060282

RESUMO

In the present study, we investigated the antitumor and immunomodulatory activity of Astragalus membranaceus polysaccharide (AMP) on liver cancer using murine H22 hepatocarcinoma model. The results showed that AMP (100 and 400 mg/kg) could effectively inhibit the solid tumor growth of H22 hepatocarcinoma transplanted in BALB/c mice. Besides, the body weight, spleen/thymus indexes and phagocytotic function of macrophage of H22 tumor bearing mice were also improved in two AMP treated groups. Furthermore, AMP treatment could promote the secretion of IL-2, IL-12 and TNF-α and decreased IL-10 level in serum. Taken together, these findings indicate that AMP has antitumor activity in vivo at least partly via improving immune responses of host organism, and seems to be safe and effective for the use of anti-tumor therapy.


Assuntos
Antineoplásicos/farmacologia , Astragalus propinquus/química , Carcinoma Hepatocelular/patologia , Fatores Imunológicos/farmacologia , Neoplasias Hepáticas/patologia , Polissacarídeos/farmacologia , Animais , Peso Corporal/efeitos dos fármacos , Carcinoma Hepatocelular/tratamento farmacológico , Carcinoma Hepatocelular/imunologia , Proliferação de Células/efeitos dos fármacos , Citocinas/sangue , Feminino , Fatores Imunológicos/uso terapêutico , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/imunologia , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Fagocitose/efeitos dos fármacos , Polissacarídeos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA